Skip to main content

Table 2 Infection burdens of groups receiving different treatments post-infection

From: Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis

Treatment

Infection burden of VVC (log10 CFU)

Before treatment

After treatment

PBS

4.76 ± 0.341

3.738 ± 0.231

Clotrimazole

4.766 ± 0.284

0.492 ± 0.170a*

L.casei/pPG612.1-BLF

4.76 ± 0.310

1.710 ± 0.390b*

L.casei/pPG612.1

4.782 ± 0.279

3.170 ± 0.252c

L.casei

4.746 ± 0.333

2.936 ± 0.259

  1. a*P < 0.01 in comparison with L.casei/pPG612.1-BLF
  2. b*P < 0.01 in comparison with L.casei/pPG612.1, L.casei and PBS
  3. cp > 0.05 in comparison with L.casei